{"title":"一种对吸烟者有益肝脏健康的新兴益生菌","authors":"Wei Jia, Xiaojiao Zheng","doi":"10.1093/lifemeta/loac033","DOIUrl":null,"url":null,"abstract":"<p><p>Cigarette smoking is considered a risk factor for nonalcoholic fatty liver disease (NAFLD). In a study recently published in <i>Nature</i>, Chen <i>et al.</i> unveiled a mechanistic role of nicotine in NAFLD progression. In addition, they identified a gut bacterium <i>Bacteroides xylanisolvens</i> that can reduce intestinal nicotine levels, and thus improve nicotine-induced NAFLD phenotypes in mice.</p>","PeriodicalId":74074,"journal":{"name":"Life metabolism","volume":" ","pages":"loac033"},"PeriodicalIF":3.4000,"publicationDate":"2022-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11749835/pdf/","citationCount":"0","resultStr":"{\"title\":\"An emerging probiotic with liver health benefits for smokers.\",\"authors\":\"Wei Jia, Xiaojiao Zheng\",\"doi\":\"10.1093/lifemeta/loac033\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Cigarette smoking is considered a risk factor for nonalcoholic fatty liver disease (NAFLD). In a study recently published in <i>Nature</i>, Chen <i>et al.</i> unveiled a mechanistic role of nicotine in NAFLD progression. In addition, they identified a gut bacterium <i>Bacteroides xylanisolvens</i> that can reduce intestinal nicotine levels, and thus improve nicotine-induced NAFLD phenotypes in mice.</p>\",\"PeriodicalId\":74074,\"journal\":{\"name\":\"Life metabolism\",\"volume\":\" \",\"pages\":\"loac033\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2022-11-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11749835/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Life metabolism\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/lifemeta/loac033\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/2/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Life metabolism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/lifemeta/loac033","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/2/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
An emerging probiotic with liver health benefits for smokers.
Cigarette smoking is considered a risk factor for nonalcoholic fatty liver disease (NAFLD). In a study recently published in Nature, Chen et al. unveiled a mechanistic role of nicotine in NAFLD progression. In addition, they identified a gut bacterium Bacteroides xylanisolvens that can reduce intestinal nicotine levels, and thus improve nicotine-induced NAFLD phenotypes in mice.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
